Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Bagi, Nels Hanson, C. Andresen, R. Pero, Roland Lariviere, C. Turner, A. Laib (2006)
The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA.Bone, 38 1
K. Mochizuki, Tetsuo Inoue (2000)
Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the ratJournal of Bone and Mineral Metabolism, 18
Tanya Hansotia, L. Baggio, Dominique Delmeire, S. Hinke, Yuichiro Yamada, K. Tsukiyama, Y. Seino, J. Holst, F. Schuit, D. Drucker (2004)
Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.Diabetes, 53 5
Kiyoshi Suzuki, C. Sugimoto, M. Takizawa, Seiichi Ishizuka, M. Kikuyama, Haruo Togawa, Y. Taguchi, Kenziro Nosaka, Yutaka Seino, H. Ishida (2000)
Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients.Diabetes research and clinical practice, 48 3
A. Parfitt, M. Drezner, F. Glorieux, J. Kanis, H. Malluche, Pierre Meunier, S. Ott, R. Recker (1987)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 2
Q. Zhong, T. Itokawa, S. Sridhar, K. Ding, D. Xie, Baolin Kang, W. Bollag, R. Bollag, M. Hamrick, K. Insogna, C. Isales (2007)
Effects of glucose-dependent insulinotropic peptide on osteoclast function.American journal of physiology. Endocrinology and metabolism, 292 2
A. Crespel, D. F., Boisvilliers, L., Gros, A., Kervran (2001)
Effects of Glucagon and Glucagon-Like Peptide-l-(736) Amide on C Cells from Rat Thyroid and Medullary Thyroid Carcinoma CA-77 Cell Line
K. Yamanouchi, E. Yada, H. Hozumi, Chiori Ueno, M. Nishihara (2004)
Analyses of hind leg skeletons in human growth hormone transgenic ratsExperimental Gerontology, 39
T. Vilsbøll, T. Krarup, C. Deacon, S. Madsbad, J. Holst (2001)
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.Diabetes, 50 3
D. Henriksen, P. Alexandersen, B. Hartmann, C. Adrian, I. Byrjalsen, H. Bone, J. Holst, C. Christiansen (2007)
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.Bone, 40 3
K. Tsukiyama, Yuichiro Yamada, C. Yamada, N. Harada, Y. Kawasaki, M. Ogura, K. Bessho, Minqi Li, N. Amizuka, Masahiro Sato, N. Udagawa, N. Takahashi, Kiyoshi Tanaka, Y. Oiso, Y. Seino (2006)
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion.Molecular endocrinology, 20 7
J. Christensen, O. Svendsen (1999)
Bone Mineral in Pre- and Postmenopausal Women with Insulin-Dependent and Non-insulin-Dependent Diabetes MellitusOsteoporosis International, 10
M. Li, Y. Shen, K. Burton, Patrick DeLuca, Rahul Mehta, B. Baumann, T. Wronski (1996)
A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.Bone, 18 4
Y. Lamari, C. Boissard, M. Moukhtar, A. Jullienne, Gabriel Rosselin, J. Garel (1996)
Expression of glucagon‐like peptide 1 receptor in a murine C cell line Regulation of calcitonin gene by glucagon‐like peptide 1FEBS Letters, 393
T. Wronski, C. Yen, K. Burton, R. Mehta, P. Newman, E. Soltis, P. DeLuca (1991)
Skeletal effects of calcitonin in ovariectomized rats.Endocrinology, 129 4
A. Huebner, T. Schinke, M. Priemel, Sarah Schilling, A. Schilling, R. Emeson, J. Rueger, M. Amling (2006)
Calcitonin Deficiency in Mice Progressively Results in High Bone TurnoverJournal of Bone and Mineral Research, 21
D. Henriksen, P. Alexandersen, N. Bjarnason, T. Vilsbøll, B. Hartmann, E. Henriksen, I. Byrjalsen, T. Krarup, J. Holst, C. Christiansen (2003)
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone ResorptionJournal of Bone and Mineral Research, 18
R. Bollag, Q. Zhong, P. Phillips, L. Min, L. Zhong, Ross Cameron, A. Mulloy, H. Rasmussen, F. Qin, K. Ding, C. Isales (2000)
Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors.Endocrinology, 141 3
Ann Schwartz (2003)
Diabetes Mellitus: Does it Affect Bone?Calcified Tissue International, 73
Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the foremost professional society serving the endocrine community
V. Rakic, W. Davis, S. Chubb, F. Islam, R. Prince, T. Davis (2006)
Bone mineral density and its determinants in diabetes: the Fremantle Diabetes StudyDiabetologia, 49
D. Henriksen, P. Alexandersen, I. Byrjalsen, B. Hartmann, H. Bone, C. Christiansen, J. Holst (2004)
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.Bone, 34 1
D. Xie, Hua Cheng, M. Hamrick, Q. Zhong, K. Ding, Daniel Correa, Sandra Williams, A. Mulloy, W. Bollag, R. Bollag, R. Runner, J. McPHERSON, K. Insogna, C. Isales (2005)
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover.Bone, 37 6
N. Udagawa, N. Takahashi, H. Yasuda, A. Mizuno, K. Itoh, Y. Ueno, T. Shinki, M. Gillespie, T. Martin, K. Higashio, T. Suda (2000)
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.Endocrinology, 141 9
Steven Kahn, S. Haffner, M. Heise, William Herman, Rury Holman, Nigel Jones, B. Kravitz, J. Lachin, M. O'neill, B. Zinman, G. Viberti (2006)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 355 23
Xiaotong Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, N. Takahashi (2002)
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.Endocrinology, 143 8
A. Schwartz, D. Sellmeyer, E. Vittinghoff, L. Palermo, B. Lecka-Czernik, K. Feingold, E. Strotmeyer, H. Resnick, L. Carbone, B. Beamer, S. Park, N. Lane, T. Harris, S. Cummings (2006)
Thiazolidinedione use and bone loss in older diabetic adults.The Journal of clinical endocrinology and metabolism, 91 9
L. Mosekilde, C. Danielsen, J. Gasser (1994)
The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.Endocrinology, 134 5
Kiyoshi Suzuki, T. Kurose, M. Takizawa, Masahiro Maruyama, K. Ushikawa, M. Kikuyama, C. Sugimoto, Y. Seino, S. Nagamatsu, H. Ishida (2005)
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.Diabetes research and clinical practice, 68 2
V. Carnevale, E. Romagnoli, E. D'erasmo (2004)
Skeletal involvement in patients with diabetes mellitusDiabetes/Metabolism Research and Reviews, 20
Giardino (1996)
Calcitonin and alendronate effects on bone quality in osteoporotic ratsJ Bone Miner Res, 21
D. Xie, Q. Zhong, K. Ding, Hua Cheng, Sandra Williams, Daniel Correa, W. Bollag, R. Bollag, K. Insogna, N. Troiano, Chistiane Coady, M. Hamrick, C. Isales (2007)
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.Bone, 40 5
S. Wallach, G. Rousseau, L. Martin, M. Azria (1999)
Effects of calcitonin on animal and in vitro models of skeletal metabolism.Bone, 25 5
T. Majima, Y. Komatsu, T. Yamada, Y. Koike, M. Shigemoto, C. Takagi, I. Hatanaka, K. Nakao (2005)
Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patientsOsteoporosis International, 16
Gastrointestinal hormones including gastric inhibitory polypeptide (GIP), glucagon-like peptide (GLP)-1, and GLP-2 are secreted immediately after meal ingestion, and GIP and GLP-2 have been shown to regulate bone turnover. We hypothesize that endogenous GLP-1 may also be important for control of skeletal homeostasis. We investigated the role of GLP-1 in the regulation of bone metabolism using GLP-1 receptor knockout (Glp-1r−/−) mice. A combination of bone density and histomorphometry, osteoclast activation studies, biochemical analysis of calcium and PTH, and RNA analysis was used to characterize bone and mineral homeostasis in Glp-1r−/− and Glp-1r+/+ littermate controls. Glp-1r−/− mice have cortical osteopenia and bone fragility by bone densitometry as well as increased osteoclastic numbers and bone resorption activity by bone histomorphometry. Although GLP-1 had no direct effect on osteoclasts and osteoblasts, Glp-1r−/− mice exhibited higher levels of urinary deoxypyridinoline, a marker of bone resorption, and reduced levels of calcitonin mRNA transcripts in the thyroid. Moreover, calcitonin treatment effectively suppressed urinary levels of deoxypyridinoline in Glp-1r−/−, mice and the GLP-1 receptor agonist exendin-4 increased calcitonin gene expression in the thyroid of wild-type mice. These findings establish an essential role for endogenous GLP-1 receptor signaling in the control of bone resorption, likely through a calcitonin-dependent pathway.
Endocrinology – Oxford University Press
Published: Feb 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.